Skip to main content

Advertisement

SpringerLink
Log in

Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harries DA, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, et al. Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis. Trop Med Int Health. 2010;15:659–63.

    Article  PubMed  Google Scholar 

  2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2,000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  3. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 Observational Studies. PLoS Medicine. 2008;5:e152. doi:10.1371/journal.pmed.0050152.

    Article  PubMed  Google Scholar 

  4. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–46.

    Article  PubMed  Google Scholar 

  5. Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect. 2009;137:203–10.

    Article  PubMed  CAS  Google Scholar 

  6. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, et al. DM and tuberculosis: the impact of the DM epidemic on tuberculosis incidence. BMC Public Health. 2007;7:234.

    Article  PubMed  Google Scholar 

  7. Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009;80:634–9.

    PubMed  Google Scholar 

  8. Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Khairul Annuar A. Tuberculosis in diabetes patients: A clinical perspective. Southeast Asian J Trop Med Public Health. 2005;36:213–20.

    PubMed  Google Scholar 

  9. Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multi-drug resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest. 2001;120:1514–9.

    Article  PubMed  CAS  Google Scholar 

  10. Chan JCN, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40.

    Article  PubMed  CAS  Google Scholar 

  11. Rampal S, Rampal L, Rahmat R, Md Zain A, Yee GL, Mohamed M, et al. Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: a nationwide population study in Malaysia. Asia Pac J Public Health. 2010;22:194–202.

    PubMed  Google Scholar 

  12. WHO. country health information profile. [Cited 2010, Aug 4]. Available from, http://www.wpro.who.int/NR/rdonlyres/DA2B128C-C64C-45FA-B1E1-D3FF8590EC71/0/19finalMAApro09.pdf.

  13. Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34:692–7.

    Article  PubMed  Google Scholar 

  14. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Med. 2007;4:1230–45.

    Article  Google Scholar 

  15. World Health Organisation. An expanded DOTS framework for effective tuberculosis contro. Int J Tuberc Lung Dis. 2002;6:378–88.

    Google Scholar 

  16. Gnanasan S, Wong KT, Mohd Ali S, Ting KN, Anderson C. Pharmacist-led medication therapy adherence clinic: exploring views of health care professionals. Int J Pharm Pract. 2010;18(Suppl 1):S24–5.

    Google Scholar 

  17. Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ. 2003;327:837–40.

    Article  PubMed  Google Scholar 

  18. Tulip S, Campbell D. Evaluating pharmaceutical care in hospitals. Hosp Pharm. 2001;8:275–9.

    Google Scholar 

  19. Medical Research Coucil. A framework for development and evaluation of RCTs for complex interventions to improve health. London: MRC. 2000.

  20. Gnanasan S, Ting KN, Wong KT, Mohd Ali S, Muttalif AR, Anderson C. Medication beliefs and concerns among patients with tuberculosis and diabetes mellitus. 16th international social pharmacy workshop. Pharm Pract (Internet). 2010;8(Suppl 1):1–136.

    Google Scholar 

  21. Gnanasan S, Wong KT, Mohd Ali S, Muttalif AR, Ting KN, Anderson C. Exploring the need for pharmaceutical care (PC) management of tuberculosis and diabetes mellitus (TBDM) in Malaysia. Abstracts of the PCNE 7th Working Conference. Pharm World Sci. 2009;31:503.

    Google Scholar 

  22. Meyer J. Qualitative research in health care. Using qualitative methods in health related action research. BMJ. 2000;320:178–81.

    Article  PubMed  CAS  Google Scholar 

  23. Hart E, Bond M. Action research for health and social care: a guide to practice: Buckingham: Open University Press. 1995.

  24. Tanna NK. Action Research: a valuable research technique for service delivery development. Pharm World Sci. 2005;27:4–6.

    Article  PubMed  Google Scholar 

  25. Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust. 2002;177:189–92.

    PubMed  Google Scholar 

  26. Tanna N, Pitkin J, Anderson C. Development of the specialist menopause pharmacist (SMP) role within a research framework. Pharm World Sci. 2005;27:61–7.

    Article  PubMed  Google Scholar 

  27. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.

    PubMed  CAS  Google Scholar 

  28. Clark PM, Karagoz T, Apikoglu-Rabus S, Vehbi IF. Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm. 2007;64:497–506.

    Article  PubMed  Google Scholar 

  29. Mitrzyk BM. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist. Pharmacotherapy. 2008;28:1243–54.

    Article  PubMed  CAS  Google Scholar 

  30. Elliott RA, Ross-Degnan D, Adans AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: Adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22:805–10.

    Article  PubMed  Google Scholar 

  31. Struijs JN, Baan CA, Schellevis FG, Westert GP, van de Bos GA. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006;6:84. doi:10.1186/1472-6963-6-84.

    Article  PubMed  Google Scholar 

  32. Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald M. Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes 2004;2. 58 doi:10.1186/1477-7525-2-58.

  33. Benson J, Britten N. Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325:873–6.

    Article  PubMed  Google Scholar 

  34. Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients’ perspectives on education-related problems. Patient Educ Couns. 2007;65:407–15.

    Article  PubMed  Google Scholar 

  35. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61:133–55.

    Article  PubMed  Google Scholar 

  36. Rao PV. Persons with type 2 diabetes and co-morbid active tuberculosis should be treated with insulin. Int J Diabetes Dev Ctries. 1999;19:79–86.

    Google Scholar 

  37. Kotokey RK, Bhattaharya D, Das P, Azad A, De A. Study of efficacy of DOTS in pulmonary tuberculosis patients with associated diabetes. Lung India. 2007;24:58–60.

    Article  Google Scholar 

  38. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676–85.

    Article  PubMed  CAS  Google Scholar 

  39. Chandran M, Chu NV, Edelman SV. Gastrointestinal disturbances in diabetes. Curr Diab Rep. 2003;3:43–8.

    Article  PubMed  Google Scholar 

  40. Javadi MR, Shalviri G, Gholami K, Salamzadeh J, Maghooli G, Mirsaeedi SM. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors. Pharmacoepidemiol Drug Saf. 2007;16:1104–10.

    Article  PubMed  Google Scholar 

  41. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167:1472–7.

    Article  PubMed  Google Scholar 

  42. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164:1749–55.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Nottingham, Nottingham, NG7 2RD, United Kingdom

    Shubashini Gnanasan & Claire Anderson

  2. University of Nottingham, Malaysia Campus, Semenyih, Malaysia

    Kang Nee Ting & Kok Thong Wong

  3. Universiti Teknologi MARA, Shah Alam, Malaysia

    Salmiah Mohd Ali

  4. Penang Hospital, Penang, Malaysia

    Abdul Razak Muttalif

Authors
  1. Shubashini Gnanasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kang Nee Ting
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kok Thong Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Salmiah Mohd Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abdul Razak Muttalif
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claire Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shubashini Gnanasan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gnanasan, S., Ting, K.N., Wong, K.T. et al. Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care. Int J Clin Pharm 33, 44–52 (2011). https://doi.org/10.1007/s11096-010-9452-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-010-9452-3

Keywords

Search

Navigation